Compare VEEV & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEV | DXCM |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3B | 28.9B |
| IPO Year | 2013 | 2005 |
| Metric | VEEV | DXCM |
|---|---|---|
| Price | $194.35 | $73.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 21 |
| Target Price | ★ $280.42 | $85.33 |
| AVG Volume (30 Days) | 1.5M | ★ 4.1M |
| Earning Date | 05-27-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.93 | ★ 47.18 |
| EPS | ★ 1.57 | 0.51 |
| Revenue | ★ $1,104,081,000.00 | N/A |
| Revenue This Year | $14.42 | $14.46 |
| Revenue Next Year | $12.17 | $12.31 |
| P/E Ratio | ★ $123.86 | $143.86 |
| Revenue Growth | ★ 28.05 | N/A |
| 52 Week Low | $148.05 | $54.11 |
| 52 Week High | $310.50 | $82.36 |
| Indicator | VEEV | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 52.51 |
| Support Level | $151.71 | $62.02 |
| Resistance Level | $201.84 | $74.08 |
| Average True Range (ATR) | 7.05 | 2.63 |
| MACD | -0.96 | -0.36 |
| Stochastic Oscillator | 87.33 | 43.09 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.